✦ LIBER ✦

EM 800 active in tamoxifen-resistant breast cancer

Book ID: 120857739
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 138 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414290-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1–43 Activity and Safety of the Antiestr

1–43 Activity and Safety of the Antiestrogen EM-800, the Orally Active Precursor of Acolbifene, in Tamoxifen-Resistant Breast Cancer

✍ Elledge, R.M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Tamoxifen Resistance in Breast Cancer

✍ Dr Lambert C. J. Dorssers, Silvia van der Flier, Arend Brinkman, Ton van Agthove 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 281 KB

Tamoxifen Resistant and Refractory Breas

Tamoxifen Resistant and Refractory Breast Cancer

✍ Professor Paul E. Goss, Kathrin Strasser 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 157 KB

Tamoxifen induced estrogen receptor acti

Tamoxifen induced estrogen receptor activity in endocrine resistant breast cancer

✍ C. Davidson; Kavanagh; E. McDermott; N. O'Higgins; A. Hill; L. Young 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Alitretinoin + tamoxifen active in metas

Alitretinoin + tamoxifen active in metastatic breast cancer

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Elucidating mechanisms of tamoxifen resi

Elucidating mechanisms of tamoxifen resistance in breast cancer

✍ Robert Carlson 📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 696 KB